<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01010815</url>
  </required_header>
  <id_info>
    <org_study_id>Gut Microbiome in UC Patients</org_study_id>
    <nct_id>NCT01010815</nct_id>
  </id_info>
  <brief_title>Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis</brief_title>
  <official_title>Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Food and Drug Safety, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers will investigate gut microbiome in Korean patients with ulcerative colitis
      and normal control subjects using metagenomic analysis to elucidate the significant
      difference between two groups This study will help to understand the association between gut
      microbiome and inflammatory bowel disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">November 2011</completion_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>characterize the difference in gut microbiomes through metagenomic analysis between UC patients and normal control subjects</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>characterize the difference in gut microbiomes through metagenomic analysis between stool specimens and biopsy specimens in participants with UC and normal subjects</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>characterize the difference in gut microbiomes among colonoscopy biopsy locations (rectum, ascending and descending colon)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>characterize the difference in gut microbiomes between active and inactive UC patients</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>UC group</arm_group_label>
    <description>clinically and microscopically confirmed UC patients between the age of 19 and 75 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>normal healthy controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy biopsy</intervention_name>
    <description>Colonoscopy biopsy will be performed in rectum, ascending and descending colon at study entry</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stool collection</intervention_name>
    <description>Stool will be collected from participants at study entry</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>colonoscopy biopsy</intervention_name>
    <description>colonoscopy biopsy will be conducted in rectum, ascending and descending colon from participants 2 times during study - at active phase and inactive phase</description>
    <arm_group_label>UC group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>stool collection</intervention_name>
    <description>stool will be collected from participants 2 times during study - at active phase and inactive phase</description>
    <arm_group_label>UC group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Participants will need to give stool samples and colorectal biopsy specimens on 1 or 2
      separate occasions
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        gastroenterology clinic at SNUH(Seoul National University Hospital)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the age of 19 and 75 years

          -  willing to consent/undergo necessary procedures

          -  clinically active or inactive Ulcerative colitis

        Exclusion Criteria:

          -  Inability to provide informed consent or

          -  Clinically severe or fulminant ulcerative colitis

          -  Previous abdominal surgery

          -  Pregnancy

          -  Clinically or laboratory-confirmed gastroenteritis for at least 3 months before
             sampling

          -  the use of antibiotics in the past a month before sampling

          -  the use of probiotics in the past a month before sampling

          -  Severe cardiovascular or pulmonary disease

          -  Severe convulsive disorder and current use of anti-convulsive medication

          -  Malignancy

          -  Transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joo Sung Kim, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joo Sung Kim, M.D., PhD</last_name>
    <phone>+82-2-740-8112</phone>
    <email>jooskim@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seong-Joon Koh, M.D.</last_name>
    <phone>+82-2-740-8112</phone>
    <email>jel1206@medimail.co.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joo Sung Kim, Ph.D</last_name>
      <phone>82-2-740-8112</phone>
      <email>jooskim@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Seong-Joon Koh</last_name>
      <phone>82-2-740-8112</phone>
      <email>jel1206@medimail.co.kr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2009</study_first_submitted>
  <study_first_submitted_qc>November 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2009</study_first_posted>
  <last_update_submitted>November 9, 2009</last_update_submitted>
  <last_update_submitted_qc>November 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Joo Sung Kim</name_title>
    <organization>Seoul National University Hospital</organization>
  </responsible_party>
  <keyword>ulcerative colitis</keyword>
  <keyword>gut microbiome</keyword>
  <keyword>metagenomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

